Wales Healthcare
Latest News
-
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization GalleryModerna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced [...]
La Roche-Posay Presents the New Acne Diagnostic Tool Powered by Artificial Intelligence
Effaclar SpotScan is the result of 2 years of work with support of renewed dermatologists and using the global acne evaluation scale (GEA) analysing over [...]
Dermatology Webinar Series
With the COVID-19 pandemic still causing disruption on a global basis, Thornton & Ross is delighted to support this series of free and accredited webinars [...]
